Characterisation of a cyclic peptide that blocks the RAS binding domain of phosphoinositide 3-kinase p110a (2022)

First Author: Ismail M

Attributed to: Cancer drug discovery targeting the interaction of RAS oncogenic proteins with phosphoinositide 3-kinase funded by FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-1854923/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-1854923/v1

Type: Preprint